Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Lymphoid 1Genitourinary 1Breast 1

Conditions

Lymphoma 8Lymphoma, Large B-Cell, Diffuse 6Hodgkin Disease 6Lymphoma, Follicular 3Breast Neoplasms 3Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Triple Negative Breast Neoplasms 1Sarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neuroendocrine Tumors 1Mycosis Fungoides 1Mesothelioma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Glioblastoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

pembrolizumab 4Paclitaxel 2vocimagene amiretrorepvec 1stenoparib 1olaparib 1mirabegron 1epacadostat 1durvalumab 1ciforadenant 1cemiplimab 1atezolizumab 1advexin 1Temozolomide 1Rituximab 1Pharmacogenomic Variants 1Nivolumab 1LTX-315 1Ipilimumab 1IACS-010759 1HMPL-013 1Gemcitabine 1Fluorodeoxyglucose F18 1Flucytosine 1Carboplatin 1Capecitabine 1CPI-006 1Brentuximab Vedotin 1Bendamustine Hydrochloride 1Antibodies 1AZD5153 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Triple Negative Breast Neoplasms × Fluorodeoxyglucose F18 × Lymphoid × Clear all
NCT02599194 2019-01-03

18F-FSPG PET/CT for Cancer Patients on Therapy

Stanford University

Phase 2 Completed
7 enrolled 6 charts
BreastGenitourinaryLymphoidOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Mesothelioma, Lymphoma, B-Cell, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡